Coherus BioSciences has announced promising results from its ongoing Phase 1 clinical trial of CHS-114, a selective anti-CCR8 antibody, in combination with toripalimab for patients with ...
The health system has sold 35% of its hospitals since 2019, but will selectively target deals aimed at further deleveraging going forward. After years of aggressive hospital sales, Community Health ...
ST. PAUL, Minn.--(BUSINESS WIRE)--CHS Inc., the nation’s leading agribusiness cooperative, has announced it intends to return $120 million in cash patronage and equity redemptions to its owners in ...
CHS Inc. operates as a diversified global agribusiness cooperative, providing products and services in energy, agronomy, grain marketing, animal nutrition, food ingredients, and risk management. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results